Zhengye Biotechnology Holding (ZYBT) Interest Expenses (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Interest Expenses for 3 consecutive years, with $3.3 million the latest figure, recorded in Q4 2025.

• Quarterly Interest Expenses rose 10289.34% year-over-year to $3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (up 10289.34% YoY) and the FY2025 annual result came in at $486000.0, down 12.27% from the prior year.
• Interest Expenses rose to $3.3 million in Q4 2025 per ZYBT's latest filing, from $15000.0 in the prior quarter.
• Over the last five years, Interest Expenses for ZYBT reached as high as $3.3 million in Q4 2025 and fell as low as $15000.0 in Q2 2025.
• A 3-year average of $841517.0 and a median of $41147.8 in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2024 — Interest Expenses sank 38.11% — and 2025, when it soared 10289.34%.
• Year by year, Interest Expenses stood at $50832.8 in 2023, then plunged by 38.11% to $31462.8 in 2024, then surged by 10289.34% to $3.3 million in 2025.
• According to Business Quant data, Interest Expenses over the past three periods registered $3.3 million, $15000.0, and $31462.8 for Q4 2025, Q2 2025, and Q4 2024 respectively.